Effects of tolvaptan discontinuation in patients with autosomal dominant polycystic kidney disease: a post hoc pooled analysis

Abstract Background Tolvaptan slows kidney function decline in patients with autosomal dominant polycystic kidney disease (ADPKD) who are at risk of rapid progression. Given that treatment requires commitment to long-term use, we evaluated the effects of tolvaptan discontinuation on the trajectory o...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Michael Lioudis, Xiaolei Zhou, Eric Davenport, Sasikiran Nunna, Holly B. Krasa, Dorothee Oberdhan, Ancilla W. Fernandes
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2023-06-01
coleção:	BMC Nephrology
Assuntos:	Autosomal dominant polycystic kidney disease (ADPKD) Tolvaptan Glomerular filtration rate Kidney volume Clinical trial Treatment
Acesso em linha:	https://doi.org/10.1186/s12882-023-03247-6
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!